However, two studies performed in stage II-III colon cancer, that analyzed the expression of 4 MMR genes by IHC, but not using TMAs, also describe high levels of MMR-deficiency, respectively 33 and 30% [53, 54]. The gene discussed is MRC1; the disease is colonic neoplasm.